Skip to main content

Table 2 Mismatch repair IHC testing results

From: Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations

GENE

Antibody

Result

MLH1

G168-15

Normal expression

PMS2

A16-4

Normal expression.

MSH6

BC/44

Loss of expression.

MSH2

FE11

Loss of expression.